Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital
Home About Us How To Help Contact Us Search

Search by Clinical Program

Alphabetical List

Search by Diagnosis

Make an Appointment

Online Specialty Consultations

Lecia Van Dam Sequist, MD, MPH

For Appointments
617-643-2189

Fax
617-726-0453

Office Address
Massachusetts General Hospital Cancer Center
Center for Thoracic Cancers
55 Fruit Street, YAW 7
Boston, MA 02114

Clinical Interests
Clinical Trials in Lung Cancer; EGFR Mutations in Lung Cancer; Circulating Tumor Cells (CTC) in Cancer Patients

Education
MD Degree: Harvard Medical School, Boston, MA, 1999
MPH: Harvard School of Public Health, Boston, MA, 2005

Postdoctoral Training
Residency: Internal Medicine, Brigham & Women's Hospital, Boston, MA
Fellowship: Hematology & Oncology, Dana-Farber/Partners CancerCare, Boston, MA

Board Certification
Internal Medicine, 2002
Medical Oncology, 2005

Academic Appointments
Instructor in Medicine, Harvard Medical School

Professional Societies
Massachusetts Medical Society
American Society of Clinical Oncology
International Association for the Study of Lung Cancer

My Publications
Link to PubMed Database

Selected Publications
Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ, Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J, Tompkins RG, Lynch TJ, Toner M, Haber DA. Detection of Mutations in EGFR in Circulating Lung-Cancer Cells. N Engl J Med. 2008 Jul 2.

Sequist LV, Martins RG, Spigel D, Grunberg SM, Spira A, Jänne PA, Joshi VA, McCollum D, Evans TL, Muzikansky A, Kuhlmann GL, Han M, Goldberg JS, Settleman J, Iafrate AJ, Engelman JA, Haber DA, Johnson BE, Lynch TJ. First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations. J Clin Oncol. 2008 May 20;26(15):2442-9.

Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007 Dec 20;450(7173):1235-9.

Sequist LV, Bell DW, Lynch TJ, Haber DA. Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer. J Clin Oncol. 2007 Feb 10;25(5):587-95. Review.

Harvard Medical School - Teaching Affiliate  
Previous Page | To Top